Patient thinks she had an allergic reaction to the vaccine; lethargic feeling; Pain in chest and throughout body similar to cold/warm sensations with pain; Patient still have burning sensation inside her body / burning sensations throughout head to toe of body; Left arm pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Pain in chest and throughout body similar to cold/warm sensations with pain), BURNING SENSATION (Patient still have burning sensation inside her body / burning sensations throughout head to toe of body), HYPERSENSITIVITY (Patient thinks she had an allergic reaction to the vaccine), LETHARGY (lethargic feeling) and VACCINATION SITE PAIN (Left arm pain at the injection site) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Amoxicillin), Latex allergy, Cosmetic allergy and Blood pressure high since 2008. Concomitant products included LISINOPRIL for Blood pressure high, VITAMIN D NOS for Vitamin supplementation.    On 27-Apr-2021 at 5:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Left arm pain at the injection site). On 01-May-2021, the patient experienced CHEST PAIN (Pain in chest and throughout body similar to cold/warm sensations with pain), BURNING SENSATION (Patient still have burning sensation inside her body / burning sensations throughout head to toe of body) and LETHARGY (lethargic feeling). On an unknown date, the patient experienced HYPERSENSITIVITY (Patient thinks she had an allergic reaction to the vaccine). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form; FAMOTIDINE (PEPCID [FAMOTIDINE]) at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYTREC) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 01-Jun-2021, CHEST PAIN (Pain in chest and throughout body similar to cold/warm sensations with pain), BURNING SENSATION (Patient still have burning sensation inside her body / burning sensations throughout head to toe of body) and LETHARGY (lethargic feeling) had resolved with sequelae. At the time of the report, HYPERSENSITIVITY (Patient thinks she had an allergic reaction to the vaccine) and VACCINATION SITE PAIN (Left arm pain at the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: high count (High) high counts to re-run in a weeks. On an unknown date, SARS-CoV-2 test: negative (Negative) negative. On an unknown date, X-ray: unknown (abnormal) unknown and.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered CHEST PAIN (Pain in chest and throughout body similar to cold/warm sensations with pain), BURNING SENSATION (Patient still have burning sensation inside her body / burning sensations throughout head to toe of body), HYPERSENSITIVITY (Patient thinks she had an allergic reaction to the vaccine), LETHARGY (lethargic feeling) and VACCINATION SITE PAIN (Left arm pain at the injection site) to be possibly related.    On 25-MAY-2021 a chest x-ray was performed however no results were provided. On 27-APR-201 patient had burning sensation in her chest and under her breast area on left side and recovered on 01-JUN-2021. With burning sensation in chest residual effect like slight sensation occurred , and with lethargy tiredness happened; and with pain in chest some slight pain occurred.   This case was linked to MOD-2021-246781 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Jul-2021: Follow-up received updated medical history and concomitant drugs. On 25-Jul-2021: follow up appended, added new reporter, lab tests, treatment information, event details added.